Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection

Am J Respir Crit Care Med. 2020 Jul 1;202(1):130-132. doi: 10.1164/rccm.202004-0937LE.

Authors

Roham T Zamanian^{1

2}, Charles V Pollack Jr³, Michael A Gentile⁴, Moira Rashid⁵, John Christian Fox⁶, Kenneth W Mahaffey¹, Vinicio de Jesus Perez^{1

2}

Affiliations

¹ Stanford University School of MedicineStanford, California.
² Vera Moulton Wall Center for Pulmonary Vascular DiseaseStanford, California.
³ University of Mississippi School of MedicineJackson, Mississippi.
⁴ Vero BiotechAtlanta, Georgia.
⁵ Private Practice Long Beach, Californiaand.
⁶ University of California Irvine Emergency MedicineOrange, California.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Inhalation
Adult
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Familial Primary Pulmonary Hypertension / therapy*
Female
Humans
Investigational New Drug Application
Nitric Oxide / therapeutic use*
Off-Label Use
Outpatients
Pandemics
Pneumonia, Viral / complications*
SARS-CoV-2
Telemedicine
Walk Test

Substances

Nitric Oxide